ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,168.00
0.52%
다우존스 지수
38,589.16
-0.15%
Bitcoin
66,639.98
0.67%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Protara Therapeutics Inc (TARA)

  7. Protara Therapeutics Inc (TARA) 뉴스

TARA

Protara Therapeutics (TARA)

Protara Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TARA
일자시간출처헤드라인심볼기업
2024/06/1107:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/06/1107:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/06/1107:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/06/1107:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/06/1107:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/06/1107:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/06/1105:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TARAProtara Therapeutics Inc
2024/06/0105:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/05/2408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/05/2121:00GlobeNewswire Inc.Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation SummitNASDAQ:TARAProtara Therapeutics Inc
2024/05/1808:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/05/1107:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/05/1013:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TARAProtara Therapeutics Inc
2024/05/1005:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TARAProtara Therapeutics Inc
2024/05/0221:00GlobeNewswire Inc.Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TARAProtara Therapeutics Inc
2024/04/0521:04GlobeNewswire Inc.Protara Therapeutics Announces Oversubscribed $45 Million Private Placement FinancingNASDAQ:TARAProtara Therapeutics Inc
2024/04/0521:02GlobeNewswire Inc.Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral NutritionNASDAQ:TARAProtara Therapeutics Inc
2024/04/0521:00GlobeNewswire Inc.Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBCNASDAQ:TARAProtara Therapeutics Inc
2024/03/1321:00GlobeNewswire Inc.Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:TARAProtara Therapeutics Inc
2024/02/2822:00GlobeNewswire Inc.Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:TARAProtara Therapeutics Inc
2024/01/2406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/2406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/2406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/2406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/2406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/1306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/1306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/1306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/0606:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/0606:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
 검색 관련기사 보기:NASDAQ:TARA

최근 히스토리

PM
XAUUSD
Gold vs US Dollar
NYSE
NKE
Nike
NASDAQ
TSLA
Tesla
NYSE
KO
Coca Cola
AMEX
XLF
Financial Select Sector
COIN
ETHUSD
Ethereum
AMEX
XLE
Energy Select Sector SPDR
NYSE
MCD
McDonalds
NYSE
BAC
Bank of America
NYSE
MRK
Merck
USOTC
ADDYY
Adidas (QX)
NYSE
CVX
Chevron
CCOM
SILVER
SILVER
COIN
BTCUSD
Bitcoin
FX
USDGBP
US Dollar vs Sterling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유